Page 6 - Sysmex Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The discrimination between active tuberculosis (ATB) and latent tuberculosis infection (LTBI) remains challenging. The present study aims to investigate the value of diagnostic models established by machine learning based on multiple laboratory data for distinguishing Mycobacterium tuberculosis (Mtb) infection status. T-SPOT, lymphocyte characteristic detection, and routine laboratory tests were performed on participants. Diagnostic models were built according to various algorithms. A total of 892 participants (468 ATB and 424 LTBI) and another 263 participants (125 ATB and 138 LTBI), were res...

Hematology is a branch of medical science concerned with diagnosis, treatment and study of blood and disorders related to blood.

In Sysmex Co. v. Beckman Coulter, Inc., 2022 U.S. Dist. LEXIS 103757 (D. Del. June 9, 2022), Judge Bataillon granted Sysmex's request to uphold the validity of several claims...

Sysmex Co. (OTCMKTS:SSMXY – Get Rating) saw a large decline in short interest during the month of May. As of May 31st, there was short interest totalling 400 shares, a decline of 90.7% from the May 15th total of 4,300 shares. Based on an average daily volume of 160,000 shares, the days-to-cover ratio is currently […]

Sysmex Co. (OTCMKTS:SSMXY – Get Rating) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 4,300 shares, a decline of 39.4% from the April 30th total of 7,100 shares. Based on an average daily trading volume, of 152,100 shares, the […]